Vyxeos liposomal
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Vyxeos liposomal, covering 2024-05-24 to 2026-08-04. Get the full timeline:
Most recent: EMA Authorised: Vyxeos liposomal (previously Vyxeos) (daunorubicin hydrochloride;cytarabine) — Jazz Pharmaceuticals Ireland Limited